The Problems of the Safety Evaluation of Biotechnology Derived Drugs

被引：0
|
作者：
L.CAPRINO
G.TOGNA
机构：
[1] Institute
[2] Institute of Medical pharmacology IV Chair of Pharmacology University of Rome "La Sapienza"
[3] P.le A.Moro 5
[4] 00185 Rome
[5] Italy
来源：
Biomedical and Environmental Sciences | 1993年 / 04期
关键词：
The Problems of the Safety Evaluation of Biotechnology Derived Drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent years have witnessed rapid advances in the toxicologic assessment of biotechproducts.Safety assessment of a biotech product is a complex and multiple process.This includes a knowledge of its pharmaco-biological characteristics,and identifyingthe target patient population and the proposed clinical application. To make a decision on the safe human application(the products are administering tohumans for therapeutic purposes),besides the identity and purity of the final product,
引用
收藏
页码：413 / 418
页数：6
相关论文
共 50 条
12345